Cargando…
Re-purposing Chloroquine for Glioblastoma: Potential Merits and Confounding Variables
There is a growing evidence that antimalarial chloroquine could be re-purposed for cancer treatment. A dozen of clinical trials have been initiated within the past 10 years to test the potential of chloroquine as an adjuvant treatment for therapy–refractory cancers including glioblastoma, one of the...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120043/ https://www.ncbi.nlm.nih.gov/pubmed/30211116 http://dx.doi.org/10.3389/fonc.2018.00335 |